Literature DB >> 29968439

Successful Medical Management of a Rare Loeffler Endocarditis Case.

Okan Gulel1, Ilkay Camlidag2, Muzaffer Elmali2.   

Abstract

Entities:  

Year:  2018        PMID: 29968439      PMCID: PMC6031717          DOI: 10.4070/kcj.2017.0348

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


× No keyword cloud information.
A 65-year-old man was admitted to the cardiology department with increasing dyspnea, orthopnea, and fatigue over the last month. Transthoracic echocardiography (TTE) revealed an ejection fraction of 60%, immobile thrombus in left ventricular (LV) apex, E/A ratio >2, biatrial dilatation, moderate mitral and tricuspid regurgitation, systolic pulmonary arterial pressure of 70 mmHg, and dilated inferior vena cava without respiratory variation (Supplementary Video 1). Blood tests were remarkable only for mild eosinophilia (1,000 cells/microliter). Similar to TTE findings, cardiac magnetic resonance imaging (MRI) showed a hypointense thrombus adjacent to LV apex with bilateral pleural effusion (Figure 1). Although only mild peripheral eosinophilia was present, bone marrow biopsy showed 25% infiltration of bone marrow with eosinophils. Based on these clinical, imaging and laboratory findings, the patient was diagnosed as having idiopathic hypereosinophilic syndrome (HES) and Loeffler endocarditis. He was administered 1 mg/kg/day methylprednisolon for three months, warfarin with a target international normalized ratio of 2 to 3, and 20 mg/day furosemide. At follow-up, his symptoms improved significantly. Control TTE performed 4 months after diagnosis showed complete resolution of thrombus with hypokinesia of LV apex (Supplementary Video 2). In addition, there was a decrease in systolic pulmonary arterial pressure by 15 mmHg without any change in E/A ratio. Control cardiac MRI confirmed TTE findings (Figure 2).
Figure 1

Pretreatment images. (A) T2-weighted cardiac MRI showing LV apical thickening marked with white asterisk. (B) Hypointense thrombus (marked with white asterisk) adjacent to LV apex on T1-weighted image after contrast administration.

LV = left ventricular; MRI = magnetic resonance imaging.

Figure 2

Posttreatment images. (A) T2-weighted cardiac MRI showing disappearance of LV apical thickening and thrombus (left ventricle). (B) Fat-saturated T1-weighted cardiac MRI after contrast administration showing disappearance of LV apical thickening and thrombus (left ventricle).

LV = left ventricular; MRI = magnetic resonance imaging.

HES is characterized by excessive production of eosinophils that subsequently involve and damage multiple organs. HES can involve almost any organ system, but cardiac involvement is a serious cause of morbidity and mortality. This rare Loeffler endocarditis case in an idiopathic HES patient is interesting in a way that typical cardiac imaging findings and bone marrow hypereosinophilia were present in the presence of mild peripheral eosinophilia. There are very few cases of Loeffler endocarditis without prominent peripheral eosinophilia in the literature. Furthermore, complete resolution of LV apical thrombus was provided by medical treatment in this rare case.
  3 in total

1.  Idiopathic eosinophilic endomyocarditis in the absence of peripheral eosinophilia.

Authors:  Ute Priglinger; Johannes Drach; Robert Ullrich; Helmut Baumgartner; Kurt Huber; Gerald Maurer
Journal:  Leuk Lymphoma       Date:  2002-01

2.  Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

Authors:  Peter Valent; Amy D Klion; Hans-Peter Horny; Florence Roufosse; Jason Gotlib; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Joseph H Butterfield; Wolfgang R Sperr; Karl Sotlar; Peter Vandenberghe; Torsten Haferlach; Hans-Uwe Simon; Andreas Reiter; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2012-03-28       Impact factor: 10.793

Review 3.  Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature.

Authors:  Jenna C Podjasek; Joseph H Butterfield
Journal:  Leuk Res       Date:  2013-01-16       Impact factor: 3.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.